Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects of giving gemcitabine, doxorubicin,
and paclitaxel together with carboplatin in treating patients with advanced bladder or kidney
cancer and impaired kidney function.